Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents.

ABSTRACT:

Background

Knowledge of the cost of illness of inflammatory bowel disease (IBD) is essential for health policy makers worldwide.

Aim

To assess the cost of illness of IBD from the societal perspective taking into account time trends and geographical differences.

Methods

A systematic review of all population-based studies on cost of illness of IBD published in Embase, Medline, Web of Science and Google Scholar. Methodology of included studies was assessed and costs were adjusted to 2018 US dollars.

Results

Study methodologies differed considerably, with large differences in perspective, valuation method and population. For prevalent Crohn's disease (CD) cases in the last ten years annual healthcare costs were in Asia $4417 (range $1230-$31 161); Europe $12 439 ($

SUBMITTER: van Linschoten RCA 

PROVIDER: S-EPMC8361769 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature